BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1357 related articles for article (PubMed ID: 1763432)

  • 1. Amyloid deposition as the central event in the aetiology of Alzheimer's disease.
    Hardy J; Allsop D
    Trends Pharmacol Sci; 1991 Oct; 12(10):383-8. PubMed ID: 1763432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of Alzheimer's disease: molecular and cellular mechanisms].
    Govaerts L; Schoenen J; Bouhy D
    Rev Med Liege; 2007 Apr; 62(4):209-16. PubMed ID: 17566391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function.
    Beyreuther K; Masters CL
    Brain Pathol; 1991 Jul; 1(4):241-51. PubMed ID: 1669714
    [No Abstract]   [Full Text] [Related]  

  • 4. Glutamate, beta-amyloid precursor proteins, and calcium mediated neurofibrillary degeneration.
    Smith-Swintosky VL; Mattson MP
    J Neural Transm Suppl; 1994; 44():29-45. PubMed ID: 7897398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: the amyloid cascade hypothesis.
    Hardy JA; Higgins GA
    Science; 1992 Apr; 256(5054):184-5. PubMed ID: 1566067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the 'amyloid cascade hypothesis'.
    Armstrong RA
    Folia Neuropathol; 2014; 52(3):211-25. PubMed ID: 25310732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of amyloid deposition in Alzheimer's disease.
    Beyreuther K; Bush AI; Dyrks T; Hilbich C; König G; Mönning U; Multhaup G; Prior R; Rumble B; Schubert W
    Ann N Y Acad Sci; 1991; 640():129-39. PubMed ID: 1776729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeletal abnormalities in Alzheimer's disease.
    Lovestone S; Anderton B
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):883-8. PubMed ID: 1467582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology.
    Wischik CM; Harrington CR; Mukaetova-Ladinska EB; Novak M; Edwards PC; McArthur FK
    Ciba Found Symp; 1992; 169():268-93; discussion 293-302. PubMed ID: 1490426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
    Kawabata S; Higgins GA; Gordon JW
    Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
    Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
    Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
    Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
    Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.